<amendment session="109" chamber="h" number="1157" updated="2013-07-17T08:16:19-04:00">
  <amends type="h" number="5672" sequence="61"/>
  <status datetime="2006-06-28T20:33:00-04:00">pass</status>
  <sponsor id="400425"/>
  <offered datetime="2006-06-28"/>
  <description>Amendment prohibits funds in the bill from being used for-- (1) the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products and Services, or (2) the Industry Trade Advisory Committee on Intellectual Property Rights unless certain membership requirements are met.</description>
  <purpose>An amendment to prohibit the use of funds from being available for the Industry Trade Advisory Committee on Chemicals, Pharmaceuticals, Health/Science Products and Services (ITAC 3) unless the membership of the committee is "fairly balanced in terms of the points of view represented" pursuant to section 5(b)(2) of the Federal Advisory Committee Act; or the Industry Trade Advisory Committee on Intellectual Property Rights (ITAC 15) unless the membership of the committee is "fairly balanced in terms of the points of view represented" pursuant to section 5(b)(2) of the Federal Advisory Committee Act.</purpose>
  <actions>
    <action datetime="2006-06-28T20:28:00-04:00">
      <text>Amendment (A061) offered by Mr. Waxman.</text>
      <reference ref="CR H4762" label="consideration"/>
      <reference ref="CR H4762" label="text"/>
    </action>
    <vote datetime="2006-06-28T20:33:00-04:00" how="by voice vote" result="pass">
      <text>On agreeing to the Waxman amendment (A061) Agreed to by voice vote.</text>
    </vote>
  </actions>
</amendment>
